Search Results
Your search for ,HIS matches 4476 pages
Showing 1451 - 1500Breast Cancer Chemoprevention Effect Maintained Long After Stopping Anastrozole Therapy
For postmenopausal women at high risk for developing breast cancer—largely based on family history—anastrozole taken for 5 years maintained a preventive effect for at least an additional 7 years after stopping the drug in the IBIS-II trial, which included nearly 4,000 subjects. Women randomly...
ASH Honors Member of Congress and Leaders of NIDDK and NCI
The American Society of Hematology (ASH) recognized representative Tom Cole (R–OK); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Hematology and Training Program Director Terry Bishop, PhD; and National Cancer Institute (NCI) Program Director William Merritt, PhD,...
A Deeper Understanding of the Miracle of the Human Body
Despite millennia of anatomic and biomedical search and discovery, there are parts and functions of the human body that remain a mystery. For years, medical students were taught that there are 78 organs in the human body. In February 2017, that number was revised, with the announcement of a new...
A Caregiver’s Tale of Struggle and Lingering Questions
The role of caregiver in the cancer scenario is complicated by various emotions and circumstances beyond the control of the caregiver and the person with cancer. Caregiver stress occurs when there isn’t the time to do all that’s asked or expected of one. Caregiver stress evolves into burnout when...
The Anesthesia Era: 1845–1875
The text and photograph here are excerpted from a four-volume series of books titled Oncology: Tumors & Treatment, A Photographic History, The Anesthesia Era: 1845–1875 by Stanley B. Burns, MD, FACS, and Elizabeth A. Burns. The photograph appears courtesy of Dr. Burns and The Burns Archive. To...
Forbes Magazine Names 2020 Class of 30 Under 30, Including Honorees in Science and Health Care
Forbes magazine released the ninth annual “30 Under 30” list Class of 2020 in December 2019, featuring the newest group of 600 young entrepreneurs, scientists, and innovative individuals who were recognized for their extraordinary accomplishments at early ages. A total of 30 honorees were selected...
Seven Haircuts
The ASCO Post is pleased to reproduce installments of the Art of Oncology as published previously in the Journal of Clinical Oncology. These articles focus on the experience of suffering from cancer or of caring for people diagnosed with cancer, and they include narratives, topical essays,...
Supportive Care in Oncology Symposium Emphasized Caring for the Whole Patient From Diagnosis to End of Life
The 2019 Supportive Care in Oncology Symposium: Advancing Palliative Research Across the Care Continuum, held this past October in San Francisco, marked the fifth anniversary of its inauguration and its last as a stand-alone ASCO thematic meeting. Since its launch in 2014 as the Palliative Care in...
Radiation Oncologist Felix Y. Feng, MD, Strives for Balance Between Work and Family Life
In this installment of the Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with Felix Y. Feng, MD, Professor of Radiation Oncology, Urology, and Medicine; George and Judy Marcus Distinguished Professor; Vice Chair of Translational Research in the Department of Radiation...
Steven N. Kalkanis, MD, Selected to Lead Henry Ford Medical Group
Following a national search, Henry Ford Health System has selected its own Steven N. Kalkanis, MD, as Chief Executive Officer of the Henry Ford Medical Group. He succeeds William A. Conway, MD, who is stepping down after more than 4 decades with the health system. Dr. Kalkanis will provide...
Optimizing Metabolic Discoveries
Obesity is a leading cause of cancer, and researchers are working to learn more about the biology behind the body’s metabolism and the promotion of cancer growth. “While we know that physical activity and a balanced diet are generally healthy, we don’t yet have the data to make personalized...
Two New Grants to Support Transformative Cancer Research
Two grants for research that could transform cancer therapies have been funded through an innovative partnership between the American Association for Cancer Research (AACR) and MPM Capital through its management of the UBS Oncology Impact Fund. This unique grant program allows investigators to...
Society for Integrative Oncology’s 16th International Conference
The Society for Integrative Oncology (SIO) hosted its 16th International Conference in New York City, October 19-21, 2019, in partnership with Memorial Sloan Kettering Cancer Center (MSK). The conference theme, “Advancing the Science and Art of Integrative Oncology,” focused on deepening the...
Selected Abstracts on Novel Therapies for Chronic Myeloid Leukemia
To complement The ASCO Post’s comprehensive coverage of the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition, here are several abstracts selected from the meeting proceedings focusing on novel therapeutic regimens for chronic myeloid leukemia (CML). For full details of...
Transplantation Specialist Karen Ballen, MD, Treasures Long-Term Connections With Her Patients
Karen Ballen, MD, an international expert in stem cell transplantation, particularly for patients who have a difficult time finding a donor, was born and reared in the Bronx in a family that encouraged academic and professional pursuits. “My grandfather was an old-fashioned pediatrician who made...
Step Counts May Help Predict Treatment Outcomes for Patients With NSCLC
A new study suggests step counters could play a role in predicting outcomes for people undergoing chemoradiation therapy for lung cancer. These findings were published by Ohri et al in the International Journal of Radiation Oncology • Biology • Physics. “I consider step counts to be a new vital...
Final Answers
Emily Johnston, MD, MS, thinks about death a lot. “I wish we would stop saying people ‘lost a battle’ with cancer when someone dies,” she said. Dr. Johnston specializes in pediatric oncology at Children’s of Alabama hospital. Conquering cancer, she believes, doesn’t simply mean surviving it—it...
Highlights From the 2019 ASCO Research Community Forum Annual Meeting
Researchers from around the country joined together for learning and collaboration at the 2019 ASCO Research Community Forum (RCF) Annual Meeting in September. During the meeting, Aisha Peterson Johnson, MD, MPH, MBA, of the U.S. Food and Drug Administration (FDA) Office of Compliance, delivered a...
V. Craig Jordan, PhD, DSc, Receives Award at Buckingham Palace
V. Craig Jordan, CMG, OBE, PhD, DSc, was presented with his Companion of the Most Distinguished Order of Saint Michael and Saint George (CMG) for services to women’s health. Prince William presented the award on November 5. Dr. Jordan was recognized for his discovery and development of selective...
Taking a Reasonable Approach to Treating Newly Diagnosed Multiple Myeloma
Multiple myeloma is a malignancy characterized by clonal proliferation of terminally differentiated plasma cells within the bone marrow. Although it leads to a host of different issues within the body, overall survival has steadily improved in recent years. “This is largely because of better...
Oncology Analytics Appoints Lee Newcomer, MD, as Strategic Advisor
Oncology Analytics, a technology-enabled service company that provides health plans, providers, and patients with an evidence-based, analytics-focused approach to utilization management, purpose-built for oncology, has announced the appointment of Lee Newcomer, MD, as a strategic advisor. Dr....
Professor Jean-Charles Soria Appointed General Director of Gustave Roussy
In a statement from Gustave Roussy on December 16, 2019, the following news was released: “By an order, the Minister of Health and Solidarity, Madame Agnès Buzyn, appointed Professor Jean-Charles Soria as General Director of Gustave Roussy for a term of 5 years. He will assume his responsibilities...
Edmondo Robinson, MD, MBA, FACP, Joins Moffitt as Chief Digital Innovation Officer
Edmondo Robinson, MD, MBA, FACP, has joined Moffitt Cancer Center in Tampa as the new Senior Vice President and Chief Digital Innovation Officer. This newly created position will be critical to Moffitt’s success and navigating a continually evolving health-care industry. Dr. Robinson brings over...
My Dream Is That Multiple Myeloma Will One Day Be in My Past and No Longer a Part of My Future
A year before my diagnosis of multiple myeloma, in 2010, my husband Paul and I moved with our six children to Monterrey, Mexico, where Paul was helping to create a venture capital industry. We were so busy settling into a new country and getting our children integrated into school that when I...
The Antiseptic Era: 1876–1900
The text and photographs here are excerpted from a four-volume series of books titled Oncology: Tumors & Treatment, A Photographic History, The Antiseptic Era: 1876–1900 by Stanley B. Burns, MD, FACS, and Elizabeth A. Burns. The photographs appear courtesy of Dr. Burns and The Burns Archive. To ...
Dana-Farber Researcher Receives Victoria Mock New Investigator Award From ONS
Robert Knoerl, PhD, RN, an Instructor in Medicine and Nurse Scientist in the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute, has been awarded the 2020 Oncology Nursing Society’s Victoria Mock New Investigator Award. Dr. Knoerl was...
Coexisting With Cancer and Depression
Among the highlights at the 2019 Supportive Care in Oncology Symposium in October was the keynote address by Thomas J. Smith, MD, FACP, FASCO, FAAHPM, the Harry J. Duffey Family Professor of Palliative Medicine and Director of Palliative Medicine at Johns Hopkins Medicine and Professor of Oncology ...
New Cancer Center and Partnership With Sarah Cannon Cancer Institute at HCA Midwest Health
Golden Valley Memorial Healthcare, a leading rural health-care organization, is proud to announce its new cancer center and partnership with Sarah Cannon Cancer Institute at HCA Midwest Health, a leader in world-class cancer care, and HCA Midwest Health, Kansas City’s largest health network and...
Ashwani Rajput, MD, Named Director of Johns Hopkins Kimmel Cancer Center for Washington, DC, Region
Ashwani Rajput, MD, a surgical oncologist and researcher, has been appointed Director of the Kimmel Cancer Center at Johns Hopkins for the Washington, DC, region. Dr. Rajput assumed his new role in November 1 and is based at Sibley Memorial Hospital in Washington, DC. Dr. Rajput specializes in the ...
How to Give Effective Presentation Feedback
Giving an effective scientific presentation, like all public speaking, is an acquired skill that takes practice to perfect. When delivered successfully, an oral presentation can be an invaluable opportunity to showcase your latest research results among your colleagues and peers. It can also...
Early Research Shows Potential New Targets in Treating Glioblastoma, Colorectal Cancer, and Pancreatic Ductal Adenocarcinoma
Glioblastoma multiforme, colorectal cancer, and pancreatic ductal adenocarcinoma represent some of the most difficult-to-treat cancers and collectively cause more than 114,000 deaths each year in the United States. A trio of recently published basic research studies in these cancers have found...
Hongchao Pan, PhD, on an Update on 5 Years of Endocrine Therapy for Early Breast Cancer
Hongchao Pan, PhD, of the University of Oxford, discusses an analysis of 86,000 women in the Early Breast Cancer Trialists’ Collaborative Group database, which showed that the risk of distant recurrence 20 years after a diagnosis of node-negative, estrogen receptor–negative early-stage breast...
Stephen Hahn, MD, Confirmed as FDA Commissioner by Senate
On December 12, the United States Senate voted 72–18 to confirm Stephen Hahn, MD, as Commissioner of the U.S. Food and Drug Administration (FDA). A radiation oncologist, Dr. Hahn was previously the Chief Medical Executive and Gilbert H. Fletcher Distinguished Memorial Chair and Professor of...
Hematologist/Oncologist Augustine L. Perrotta, DO, Dies at 80
On November 24, hematologist/oncologist Augustine L. Perrotta, DO, died, days before his 81st birthday. Ironically, Dr. Perrotta died of renal cell carcinoma, presenting with metastasis to the spine, a topic about which he had written and lectured extensively. Clinical Professor of Medicine at...
Scott A. Gerber, PhD, Named Inaugural Kenneth E. and Carol L. Weg Distinguished Professor at Dartmouth
Scott A. Gerber, PhD, has been named the Kenneth E. and Carol L. Weg Distinguished Professor at Geisel School of Medicine at Dartmouth College. Dr. Gerber is the first to hold this newly established professorship. Dr. Gerber is Professor of Molecular and Systems Biology and of Biochemistry and...
Alan Hutson, PhD, MA, to Serve on St. Jude Children’s Research Hospital Data Safety Monitoring Board
Alan Hutson, PhD, MA, now holds a 5-year term as a biostatistics expert for the data safety monitoring board at St. Jude Children’s Research Hospital. Dr. Hutson is Chair and Professor of Oncology in the Department of Biostatistics and Bioinformatics at Roswell Park Comprehensive Cancer Center. At ...
An Early Interest in Biology and People Led to a Career in Oncology for Nina Shah, MD
Multiple myeloma expert Nina Shah, MD, was born and reared in the Northeast. During grade school, she developed a passion for science that would lead to an early decision to pursue a career in medicine. “My ninth-grade biology class really got me interested in human biology, and that’s when I...
Mary Jo Turk, PhD, Named O. Ross McIntyre, MD, Professor at Dartmouth College
Mary Jo Turk, PhD, has been named the O. Ross McIntyre, MD, Professor at the Geisel School of Medicine at Dartmouth College. Professor of Microbiology and Immunology and Co-Director of the Immunology and Cancer Immunotherapy Program at Dartmouth’s Norris Cotton Cancer Center, Dr. Turk joined the...
IASLC Appoints Chandra P. Belani, MD, as New Chief Science Officer
The International Association for the Study of Lung Cancer (IASLC) has named Chandra P. Belani, MD, as its new Chief Science Officer. In this position, Dr. Belani will direct, guide, and support the IASLC scientific strategy, including, but not limited to, scientific research projects,...
Your Stories Podcast Returns in 2020 With New Episodes
A new season of Your Stories, the popular podcast series from Conquer Cancer®, the ASCO Foundation, will premiere in 2020. New episodes will be released bimonthly and will feature candid conversations among doctors, patients, caregivers, and research pioneers on their experiences conquering ...
I Do Not Have a Multiple Myeloma Precursor Condition. Why Not?
For the country, and for me personally, 2001 was a watershed year. In May, my mother died; the following month my brother, Dom, then 57, called to tell me he had just been diagnosed with multiple myeloma. Except for some fatigue Dom had complained about at our mother’s funeral, there were no...
ASH 2019: PET-Directed Therapy for Early-Stage DLBCL
Most people diagnosed with early-stage, or limited, diffuse large B-cell lymphoma (DLBCL) may be able to safely skip radiation treatment after a clear positron-emission tomography (PET) scan, according to new clinical trial results from SWOG presented by Persky et al at the 2019 American Society of ...
Expert Point of View: Angela Lamarca, MD, PhD, Ian Chau, MD, and Per Pfeiffer, MD, PhD
Angela Lamarca, MD, PhD, of the Christie NHS Foundation Trust, Manchester, United Kingdom, served as European Society for Medical Oncology (ESMO) commentator for the ClarIDHy trial in a press briefing held during the ESMO Congress 2019. Dr. Lamarca acknowledged, “The reported median...
Expert Point of View: Joshua Richter, MD
Joshua Richter, MD, Assistant Professor of Medicine, Hematology, and Medical Oncology at the Tisch Cancer Institute at Mount Sinai in New York, offered his thoughts on the CANDOR study, noting that the findings point to “a new and exciting treatment regimen for our patients with relapsed and...
ASH 2019: CAR-NK Therapy for B-Cell Malignancies Shows Activity in Preclinical Studies
Preclinical studies have provided the first evidence that cellular immunotherapy for B-cell cancers could ultimately become an off-the-shelf product, capable of being uniformly manufactured in large quantities. The product—FT596—is among the first cellular immunotherapies to be based on...
Multidimensional Palliative Care: Fewer Opioids, More Pain Control in Patients With Advanced Cancer
For opioid-tolerant patients with advanced cancer experiencing pain, relief does not necessarily have to come from a higher dose of opioids, according to findings presented at the 2019 Supportive Care in Oncology Symposium.1 The results of a retrospective analysis of 300 patients with advanced...
Is Nonmetastatic Castration-Resistant Prostate Cancer a Valid Disease Category?
Does nonmetastatic castration-resistant prostate cancer really exist? Although it is considered a disease category, it turns out that the definition depends on the type of imaging used. Many patients with castration-resistant prostate cancer who were categorized as “nonmetastatic” on conventional...
RSNA 2019: High-Dose Brachytherapy for Older Patients With Nonmelanoma Skin Cancer
High-dose brachytherapy for elderly patients with nonmelanoma skin cancer produces excellent cure rates and cosmetic outcomes, according to a new study presented at the 2019 annual meeting of the Radiological Society of North America (RSNA) (Abstract SSM24-02). “For elderly patients [with...
Checkpoint Inhibitor Pneumonitis: A Pulmonologist’s Perspective
Oncologists have become accustomed to seeing pneumonitis associated with immune checkpoint inhibitor treatment in non–small cell lung cancer (NSCLC), requiring intervention by pulmonologists in the management of severe cases. At CHEST 2019, the annual meeting of the American College of Chest...
MSKCC Awards Young Investigators 2019 Paul Marks Prize for Cancer Research
Memorial Sloan Kettering Cancer Center (MSK) has named three investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes scientists for their accomplishments in the area of cancer research. The winners for 2019 are Nathanael S. Gray, PhD; Joshua...
